Viewing Study NCT01578967


Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2025-12-25 @ 10:48 PM
Study NCT ID: NCT01578967
Status: COMPLETED
Last Update Posted: 2021-12-07
First Post: 2012-04-13
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization: